Melvyn Kahan

Targeting C-reactive protein for the treatment of cardiovascular disease

Mark B. Pepys, Gideon M. Hirschfield, Glenys A. Tennent et al. · Nature · 2006 · 676 citations · Full text

Medicine, Cardiology, Pharmacology +14

Antibodies to human serum amyloid P component eliminate visceral amyloid deposits

Karl Bodin, Stéphan Ellmerich, Melvyn Kahan et al. · Nature · 2010 · 338 citations · Full text

Pharmacy, Biochemistry, Pathology +10

Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice

Gideon M. Hirschfield, J. Ruth Gallimore, Melvyn Kahan et al. · Proceedings of the National Academy of Sciences · 2005 · 192 citations

Veterinary Medicine, Pathobiology, Pathology +16

Proinflammatory Effects of Bacterial Recombinant Human C-Reactive Protein Are Caused by Contamination With Bacterial Products, Not by C-Reactive Protein Itself

Mark B. Pepys, Philip N. Hawkins, Melvyn Kahan et al. · Circulation Research · 2005 · 136 citations · Full text

Life Sciences, Immunology, Pathology +14

Transgenic human CRP is not pro-atherogenic, pro-atherothrombotic or pro-inflammatory in apoE−/− mice

Glenys A. Tennent, Winston L. Hutchinson, Melvyn Kahan et al. · Atherosclerosis · 2007 · 97 citations

Veterinary Medicine, Molecular Biology, Pathology +10